about
Potential Use of Phenolic Acids as Anti-Candida Agents: A ReviewAdvances in targeting the vacuolar proton-translocating ATPase (V-ATPase) for anti-fungal therapyReverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulenceCalcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2pIdentification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides GenusXenobiotic efflux in bacteria and fungi: a genomics updateComparative genomics allowed the identification of drug targets against human fungal pathogens.Evaluation of intravenous regional perfusion with amphotericin B and dimethylsulfoxide to treat horses for pythiosis of a limbIn vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis.The diversity of anti-microbial secondary metabolites produced by fungal endophytes: an interdisciplinary perspective.Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.Efflux-mediated antifungal drug resistance.A complex game of hide and seek: the search for new antifungalsBlad-Containing Oligomer Fungicidal Activity on Human Pathogenic Yeasts. From the Outside to the Inside of the Target Cell.The Mechanistic Targets of Antifungal Agents: An Overview.Attenuation of Candida albicans virulence with focus on disruption of its vacuole functionsBioactive Secondary Metabolites Produced by the Fungal Endophytes of Conifers.Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.Genetic validation and spectroscopic detailing of DHN-melanin extracted from an environmental fungus.Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.Differential activities of three families of specific beta(1,3)glucan synthase inhibitors in wild-type and resistant strains of fission yeastTetrahydrocarbazoles are a novel class of potent P-type ATPase inhibitors with antifungal activity.Immune-Stimulatory and Therapeutic Activity of Tinospora cordifolia: Double-Edged Sword against Salmonellosis.
P2860
Q26770692-ABA373A6-B216-40DA-B04F-969545EEB381Q26995458-E27AF168-65C4-41D1-BB60-5D11FE684408Q28472787-52F508A1-4D18-49E1-BD7A-63B4D0EA0823Q28484616-D1872E9A-8042-4279-9880-721EFB730F03Q28550999-78D202BE-EFB8-49B6-9863-E2747B250840Q28834633-48163A59-BF70-4C92-994C-CE5220526C30Q33805404-1550CBED-553E-4E51-A337-28F3244730ABQ35691426-F91F61DA-3FF7-4DEC-A92C-A0159AAE2F69Q36018571-4FB93C33-7A93-4D46-96CF-58E64C719EE4Q36718584-A6D98CB1-97BA-4C54-90EF-533038AC90A8Q37005474-C0B93892-4FB6-4CAA-BEF4-18764A95C76EQ37156645-380F4FC3-BB10-40C6-B1E9-1BD99F4E6540Q37344546-50570091-F0BD-4108-A105-E3775C73CCA4Q37438608-9B633D72-81C3-4E9F-8719-EEDAE46125D4Q37562147-15F44843-3F08-48BC-B8EF-E46E4B94219CQ38207033-DCCCD53A-7D7D-4700-8E84-54AB88FC3CA1Q38669681-FB368F06-F66A-45AE-9860-E529D1A17125Q38810307-A989FD99-FCE3-4A05-BD55-9FDC35C6C60BQ41682034-2A45762C-2E6D-4D1C-9717-0256C5EF2D91Q41703512-E18AF77B-77C0-4542-923A-A2E2917D3A4BQ42584992-533A8B9C-5089-440C-9D94-9E5FD85B3C4FQ47224179-D672045D-5455-4FE9-8064-57DFDA46E898Q48274901-9B7EC0D1-219B-40AA-A66D-0278E6AC2713
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
In search of the holy grail of antifungal therapy
@ast
In search of the holy grail of antifungal therapy
@en
type
label
In search of the holy grail of antifungal therapy
@ast
In search of the holy grail of antifungal therapy
@en
prefLabel
In search of the holy grail of antifungal therapy
@ast
In search of the holy grail of antifungal therapy
@en
P2093
P2860
P1476
In search of the holy grail of antifungal therapy
@en
P2093
Donna C Sullivan
John D Cleary
Stanley W Chapman
P2860
P304
197-215; discussion 215-6
P577
2008-01-01T00:00:00Z